EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $173 | -99.9% | 10,842 | +3.3% | 0.00% | 0.0% |
| Q3 2022 | $164,000 | +141.2% | 10,493 | +217.4% | 0.00% | – |
| Q2 2022 | $68,000 | +9.7% | 3,306 | +19.0% | 0.00% | – |
| Q1 2022 | $62,000 | +19.2% | 2,778 | -2.8% | 0.00% | – |
| Q4 2021 | $52,000 | -13.3% | 2,857 | 0.0% | 0.00% | – |
| Q3 2021 | $60,000 | +81.8% | 2,857 | +53.9% | 0.00% | – |
| Q2 2021 | $33,000 | -19.5% | 1,857 | 0.0% | 0.00% | – |
| Q1 2021 | $41,000 | 0.0% | 1,857 | -9.8% | 0.00% | – |
| Q4 2020 | $41,000 | +64.0% | 2,058 | +94.5% | 0.00% | – |
| Q3 2020 | $25,000 | 0.0% | 1,058 | 0.0% | 0.00% | – |
| Q2 2020 | $25,000 | -13.8% | 1,058 | -36.2% | 0.00% | – |
| Q1 2020 | $29,000 | +26.1% | 1,658 | +26.8% | 0.00% | – |
| Q4 2019 | $23,000 | -42.5% | 1,308 | -21.3% | 0.00% | -100.0% |
| Q1 2019 | $40,000 | – | 1,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |